Arcturus Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $21,000 | $38,815 | $45,976 | $32,598 |
Gross Profit | 21,000 | 41,673 | 45,076 | 38,012 |
EBITDA | -17,851 | -9,825 | -16,466 | -25,545 |
EBIT | -18,670 | -10,737 | -17,366 | -26,449 |
Net Income | -30,005 | -6,903 | -17,216 | -26,817 |
Net Change In Cash | 21,000 | 38,815 | 45,976 | 32,598 |
Free Cash Flow | -284 | -23,493 | -30,172 | -5,797 |
Cash | 237,028 | 237,178 | 315,329 | 288,396 |
Basic Shares | 27,000 | 27,062 | 26,967 | 26,879 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $152,310 | $157,748 | $205,755 | $12,359 |
Gross Profit | 152,310 | 154,791 | 62,704 | -159,501 |
EBITDA | -77,401 | -24,166 | 13,704 | -201,659 |
EBIT | -80,945 | -27,123 | 12,177 | -202,852 |
Net Income | -80,941 | -29,725 | 9,349 | -206,863 |
Net Change In Cash | 152,310 | 157,748 | 205,755 | 12,359 |
Cost of Revenue | -90,433 | |||
Free Cash Flow | -60,395 | -21,000 | 24,267 | -138,449 |
Cash | 237,028 | 292,005 | 391,883 | 370,492 |
Basic Shares | 27,000 | 26,628 | 27,093 | 26,317 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.11 |
2024-09-30 | -$0.26 |
2024-06-30 | -$0.64 |
2024-03-31 | -$1 |
